OrthoPediatrics (NASDAQ:KIDS) Rating Increased to Hold at Wall Street Zen

Wall Street Zen upgraded shares of OrthoPediatrics (NASDAQ:KIDS) from a sell rating to a hold rating in a report released on Saturday.

Several other research firms have also recently issued reports on KIDS. Stifel Nicolaus lowered their price objective on OrthoPediatrics from $32.00 to $20.00 and set a “buy” rating on the stock in a report on Friday, October 10th. Canaccord Genuity Group initiated coverage on OrthoPediatrics in a research note on Wednesday, December 10th. They issued a “buy” rating and a $24.00 price target on the stock. Weiss Ratings reiterated a “sell (e+)” rating on shares of OrthoPediatrics in a research report on Wednesday, October 8th. BTIG Research restated a “buy” rating and issued a $23.00 price objective on shares of OrthoPediatrics in a report on Wednesday, October 29th. Finally, Piper Sandler decreased their price objective on OrthoPediatrics from $30.00 to $22.00 and set an “overweight” rating on the stock in a report on Friday, October 10th. Eight equities research analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, OrthoPediatrics has an average rating of “Moderate Buy” and a consensus price target of $24.00.

OrthoPediatrics Trading Down 1.9%

Shares of KIDS stock opened at $18.35 on Friday. OrthoPediatrics has a 1-year low of $15.28 and a 1-year high of $27.60. The company has a market cap of $460.16 million, a price-to-earnings ratio of -9.41 and a beta of 1.09. The company has a debt-to-equity ratio of 0.28, a current ratio of 7.40 and a quick ratio of 3.52. The stock has a 50 day simple moving average of $17.86 and a 200-day simple moving average of $19.01.

OrthoPediatrics (NASDAQ:KIDS) last issued its quarterly earnings results on Tuesday, October 28th. The company reported ($0.24) EPS for the quarter, topping the consensus estimate of ($0.26) by $0.02. The company had revenue of $61.25 million during the quarter, compared to analyst estimates of $63.63 million. OrthoPediatrics had a negative net margin of 20.06% and a negative return on equity of 6.86%. On average, equities research analysts expect that OrthoPediatrics will post -0.93 EPS for the current fiscal year.

Hedge Funds Weigh In On OrthoPediatrics

A number of institutional investors have recently bought and sold shares of KIDS. Tudor Investment Corp ET AL increased its holdings in shares of OrthoPediatrics by 36.6% during the 3rd quarter. Tudor Investment Corp ET AL now owns 70,935 shares of the company’s stock worth $1,314,000 after buying an additional 19,004 shares during the last quarter. Nantahala Capital Management LLC purchased a new position in OrthoPediatrics in the third quarter worth approximately $916,000. Millennium Management LLC increased its stake in OrthoPediatrics by 20.8% during the third quarter. Millennium Management LLC now owns 943,655 shares of the company’s stock worth $17,486,000 after acquiring an additional 162,628 shares during the last quarter. Aquatic Capital Management LLC raised its position in OrthoPediatrics by 149.7% in the third quarter. Aquatic Capital Management LLC now owns 17,729 shares of the company’s stock valued at $329,000 after purchasing an additional 10,629 shares during the period. Finally, Deerfield Management Company L.P. lifted its stake in shares of OrthoPediatrics by 1,153.4% in the 3rd quarter. Deerfield Management Company L.P. now owns 194,109 shares of the company’s stock valued at $3,597,000 after purchasing an additional 178,623 shares during the last quarter. 69.05% of the stock is owned by hedge funds and other institutional investors.

OrthoPediatrics Company Profile

OrthoPediatrics Corp., founded in 2007 and headquartered in Warsaw, Indiana, is a medical device company dedicated exclusively to providing orthopedic solutions for children. The company focuses on developing, manufacturing and marketing a broad portfolio of implants and instruments designed to address a wide range of pediatric conditions, including trauma, deformity correction, spine disorders and sports injuries.

The company’s product lines include locking plates and screws for upper and lower extremity reconstruction, intramedullary nails for femur and tibia stabilization, and specialized systems such as the MAGEC Magnetic Growth Rod for treatment of early-onset scoliosis.